KIMBERLY TODD: Open Payments
NPI 1083086425 · HILTON HEAD ISLAND, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,636 in 104 payments from 40 companies in 2025. Trend: 2023 $2,545 · 2024 $2,995 · 2025 $2,636
Food & beverage: $2,465Education: $171
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $221 |
| Merck Sharp & Dohme LLC | 10 | $217 |
| AstraZeneca Pharmaceuticals LP | 7 | $200 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $163 |
| BeOne Medicines USA, Inc. | 6 | $159 |
| Novartis Pharmaceuticals Corporation | 8 | $153 |
| Astellas Pharma US Inc | 3 | $139 |
| E.R. Squibb & Sons, L.L.C. | 5 | $94 |
| Stemline Therapeutics Inc. | 3 | $73 |
| Genentech USA, Inc. | 3 | $71 |
Products named: KEYTRUDA, LYNPARZA, BRUKINSA, IBRANCE, KISQALI, OPDIVO, SARCLISA, XTANDI.
Industry payments across SC — which companies pay providers there.
